AKTX
Akari Therapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$9.66
+18.09%Next report
Analyst consensus
- Next report date
- Dec 4, 2026
- EPS estimate
- -$2.23
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$272
- EPS estimate
- -$1.04
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -12192222.5%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$1.04 | -$272 | Miss -26053.85% | — |
| May 19, 2026 | -$1.33 | -$688 | Miss -51629.32% | — |
| Nov 13, 2025 | -$0.04 | -$19.5K | Miss -48690628.18% | — |
| Aug 13, 2025 | — | -$120 | — | — |
| Apr 16, 2025 | -$1.00 | -$6.79 | Miss -578.72% | — |
| Mar 28, 2025 | — | -$0.16 | — | — |
| Nov 19, 2024 | -$0.60 | -$0.00 | Beat 99.98% | — |
| Aug 19, 2024 | -$1.00 | -$0.00 | Beat 99.96% | — |
| May 15, 2024 | -$1.00 | -$0.00 | Beat 99.96% | — |
| Oct 3, 2023 | -$0.60 | -$0.00 | Beat 99.94% | — |
| May 1, 2023 | -$0.07 | $0.00 | Beat 100.19% | — |
| Mar 9, 2023 | — | -$0.00 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 4, 2026